350 related articles for article (PubMed ID: 17100876)
1. Human natural killer cell development.
Freud AG; Caligiuri MA
Immunol Rev; 2006 Dec; 214():56-72. PubMed ID: 17100876
[TBL] [Abstract][Full Text] [Related]
2. Purification of human NK cell developmental intermediates from lymph nodes and tonsils.
Freud AG; Caligiuri MA
Methods Mol Biol; 2010; 612():1-14. PubMed ID: 20033630
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow versus thymic pathways of natural killer cell development.
Di Santo JP; Vosshenrich CA
Immunol Rev; 2006 Dec; 214():35-46. PubMed ID: 17100874
[TBL] [Abstract][Full Text] [Related]
4. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.
Freud AG; Becknell B; Roychowdhury S; Mao HC; Ferketich AK; Nuovo GJ; Hughes TL; Marburger TB; Sung J; Baiocchi RA; Guimond M; Caligiuri MA
Immunity; 2005 Mar; 22(3):295-304. PubMed ID: 15780987
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing features of developing natural killer cells.
Vosshenrich CA; Samson-Villéger SI; Di Santo JP
Curr Opin Immunol; 2005 Apr; 17(2):151-8. PubMed ID: 15766674
[TBL] [Abstract][Full Text] [Related]
6. Taking license with natural killer cell maturation and repertoire development.
Parham P
Immunol Rev; 2006 Dec; 214():155-60. PubMed ID: 17100883
[TBL] [Abstract][Full Text] [Related]
7. Production and differentiation of NK linkage cells in bone marrow.
Pollack SB
Nat Immun; 1993; 12(4-5):177-93. PubMed ID: 8257825
[TBL] [Abstract][Full Text] [Related]
8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
9. Isolation and analysis of human natural killer cell subsets.
Ferlazzo G
Methods Mol Biol; 2008; 415():197-213. PubMed ID: 18370156
[TBL] [Abstract][Full Text] [Related]
10. Human natural killer cell development in secondary lymphoid tissues.
Freud AG; Yu J; Caligiuri MA
Semin Immunol; 2014 Apr; 26(2):132-7. PubMed ID: 24661538
[TBL] [Abstract][Full Text] [Related]
11. Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15.
Haraguchi K; Suzuki T; Koyama N; Kumano K; Nakahara F; Matsumoto A; Yokoyama Y; Sakata-Yanagimoto M; Masuda S; Takahashi T; Kamijo A; Takahashi K; Takanashi M; Okuyama Y; Yasutomo K; Sakano S; Yagita H; Kurokawa M; Ogawa S; Chiba S
J Immunol; 2009 May; 182(10):6168-78. PubMed ID: 19414770
[TBL] [Abstract][Full Text] [Related]
12. Licensing of natural killer cells by self-major histocompatibility complex class I.
Yokoyama WM; Kim S
Immunol Rev; 2006 Dec; 214():143-54. PubMed ID: 17100882
[TBL] [Abstract][Full Text] [Related]
13. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
[TBL] [Abstract][Full Text] [Related]
14. Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell.
Perussia B; Chen Y; Loza MJ
Mol Immunol; 2005 Feb; 42(4):385-95. PubMed ID: 15607789
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin promotes the development of natural killer cells from hematopoietic stem cells.
Chung JW; Kim MS; Piao ZH; Jeong M; Yoon SR; Shin N; Kim SY; Hwang ES; Yang Y; Lee YH; Kim YS; Choi I
Stem Cells; 2008 Aug; 26(8):2114-23. PubMed ID: 18535152
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.
Colonna M
Immunity; 2009 Jul; 31(1):15-23. PubMed ID: 19604490
[TBL] [Abstract][Full Text] [Related]
17. Bovine natural killer cells.
Boysen P; Storset AK
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):163-77. PubMed ID: 19339058
[TBL] [Abstract][Full Text] [Related]
18. Developmental pathways that generate natural-killer-cell diversity in mice and humans.
Huntington ND; Vosshenrich CA; Di Santo JP
Nat Rev Immunol; 2007 Sep; 7(9):703-14. PubMed ID: 17717540
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic activation of the cytotoxic phenotype during human NK cell development.
Meade JL; Wilson EB; Holmes TD; de Wynter EA; Brett P; Straszynski L; Ballard PA; Trapani JA; McDermott MF; Cook GP
J Immunol; 2009 Jul; 183(2):803-13. PubMed ID: 19570824
[TBL] [Abstract][Full Text] [Related]
20. [Homeostasis of natural killer cells].
Rouzaire P; Mayol K; Viel S; Bienvenu J; Walzer T
Med Sci (Paris); 2012 Apr; 28(4):403-8. PubMed ID: 22549868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
